胺素的快速抗抑郁作用是由Ca2+透AMPA受体介导的
Anastasiya Zaytseva1, Evelina Bouckova1, McKennon J Wiles1
1Molecular, Cellular and Integrative Neurosciences Program, Colorado State University, Fort Collins, United States.
eLife
|June 26, 2023
概括
胺素通过通过氨酸抑制促进透AMPA受体 (CP-AMPARs) 迅速降低抑郁症. 这增强了突触强度,解释了胺的作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 胺素的快速抗抑郁作用是矛盾的,因为它阻断了NMDA受体 (NMDARs),这些受体对刺激信号至关重要.
- 尽管有NMDAR的对抗作用,但氨酸增强神经元活动并产生抗抑郁作用的确切机制尚不清楚.
研究的目的:
- 阐明基他胺快速抗抑郁作用的分子机制.
- 为了研究胺如何影响海马体中的谷氨酸激素信号传递和神经元活动.
主要方法:
- 培养的小鼠海马神经元用胺治疗,以评估Ca2+信号传递,氨酸活性和AMPA受体 (AMPAR) 亚单元酸化.
- 小鼠接受了亚麻醉剂的胺剂量,随后对海马突触蛋白水平和行为测试 (开放场地,尾部悬浮) 的分析.
- 在体内使用CP-AMPAR抗剂来评估CP-AMPARs的作用.
主要成果:
- 胺治疗降低了Ca2+和氨酸活性,导致GluA1酸化和CP-AMPARs在培养神经元中的表达增加.
- 在小鼠中,胺增加了海马突触GluA1水平和酸化,与减少的氨酸活性相关.
- 胺快速降低了小鼠的焦虑和抑郁类行为,这种效应被CP-AMPAR对抗消除了.
结论:
- 胺激素通过抑制氨酸活性来促进CP-AMPARs的表达.
- 这种胺诱导的CP-AMPARs增加增强了突触强度,调解了快速的抗抑郁作用.
- 这些发现揭示了胺治疗作用的新机制,涉及增强的谷氨酸可塑性.
相关概念视频
01:24Parenteral Anesthetics: Overview
160
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
160
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
204
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
204
01:23Antidepressant Drugs: MAOIs and Other Agents
279
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
279
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
01:25Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
01:30Electroconvulsive Therapy
75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75